0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Targeted Protein Degradation Drug Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-33U16564
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Targeted Protein Degradation Drug Market Research Report 2024
BUY CHAPTERS

Global Targeted Protein Degradation Drug Market Research Report 2025

Code: QYRE-Auto-33U16564
Report
September 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Targeted Protein Degradation Drug Market

The global market for Targeted Protein Degradation Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Targeted Protein Degradation Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Targeted Protein Degradation Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Targeted Protein Degradation Drug in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Targeted Protein Degradation Drug include Arvinas, Kangpu Biopharmaceuticals, Ranok Therapeutics, Accutar Biotechnology, BeiGene Ltd., Hinova Pharmaceuticals, Haisco Pharmaceutical, Nurix, Kymera Therapeutics, C4 Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Targeted Protein Degradation Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Protein Degradation Drug.
The Targeted Protein Degradation Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Targeted Protein Degradation Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Protein Degradation Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Targeted Protein Degradation Drug Market Report

Report Metric Details
Report Name Targeted Protein Degradation Drug Market
Segment by Type
  • PROTAC
  • Molecular Glue
Segment by Application
  • Cancer
  • Autoimmune Diseases
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Arvinas, Kangpu Biopharmaceuticals, Ranok Therapeutics, Accutar Biotechnology, BeiGene Ltd., Hinova Pharmaceuticals, Haisco Pharmaceutical, Nurix, Kymera Therapeutics, C4 Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Targeted Protein Degradation Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Targeted Protein Degradation Drug Market report?

Ans: The main players in the Targeted Protein Degradation Drug Market are Arvinas, Kangpu Biopharmaceuticals, Ranok Therapeutics, Accutar Biotechnology, BeiGene Ltd., Hinova Pharmaceuticals, Haisco Pharmaceutical, Nurix, Kymera Therapeutics, C4 Therapeutics

What are the Application segmentation covered in the Targeted Protein Degradation Drug Market report?

Ans: The Applications covered in the Targeted Protein Degradation Drug Market report are Cancer, Autoimmune Diseases, Other

What are the Type segmentation covered in the Targeted Protein Degradation Drug Market report?

Ans: The Types covered in the Targeted Protein Degradation Drug Market report are PROTAC, Molecular Glue

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Protein Degradation Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PROTAC
1.2.3 Molecular Glue
1.3 Market by Application
1.3.1 Global Targeted Protein Degradation Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Protein Degradation Drug Market Perspective (2020-2031)
2.2 Global Targeted Protein Degradation Drug Growth Trends by Region
2.2.1 Global Targeted Protein Degradation Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Targeted Protein Degradation Drug Historic Market Size by Region (2020-2025)
2.2.3 Targeted Protein Degradation Drug Forecasted Market Size by Region (2026-2031)
2.3 Targeted Protein Degradation Drug Market Dynamics
2.3.1 Targeted Protein Degradation Drug Industry Trends
2.3.2 Targeted Protein Degradation Drug Market Drivers
2.3.3 Targeted Protein Degradation Drug Market Challenges
2.3.4 Targeted Protein Degradation Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Protein Degradation Drug Players by Revenue
3.1.1 Global Top Targeted Protein Degradation Drug Players by Revenue (2020-2025)
3.1.2 Global Targeted Protein Degradation Drug Revenue Market Share by Players (2020-2025)
3.2 Global Targeted Protein Degradation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Targeted Protein Degradation Drug Revenue
3.4 Global Targeted Protein Degradation Drug Market Concentration Ratio
3.4.1 Global Targeted Protein Degradation Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Protein Degradation Drug Revenue in 2024
3.5 Global Key Players of Targeted Protein Degradation Drug Head office and Area Served
3.6 Global Key Players of Targeted Protein Degradation Drug, Product and Application
3.7 Global Key Players of Targeted Protein Degradation Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Protein Degradation Drug Breakdown Data by Type
4.1 Global Targeted Protein Degradation Drug Historic Market Size by Type (2020-2025)
4.2 Global Targeted Protein Degradation Drug Forecasted Market Size by Type (2026-2031)
5 Targeted Protein Degradation Drug Breakdown Data by Application
5.1 Global Targeted Protein Degradation Drug Historic Market Size by Application (2020-2025)
5.2 Global Targeted Protein Degradation Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Targeted Protein Degradation Drug Market Size (2020-2031)
6.2 North America Targeted Protein Degradation Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Targeted Protein Degradation Drug Market Size by Country (2020-2025)
6.4 North America Targeted Protein Degradation Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Protein Degradation Drug Market Size (2020-2031)
7.2 Europe Targeted Protein Degradation Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Targeted Protein Degradation Drug Market Size by Country (2020-2025)
7.4 Europe Targeted Protein Degradation Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Protein Degradation Drug Market Size (2020-2031)
8.2 Asia-Pacific Targeted Protein Degradation Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Targeted Protein Degradation Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Targeted Protein Degradation Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Protein Degradation Drug Market Size (2020-2031)
9.2 Latin America Targeted Protein Degradation Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Targeted Protein Degradation Drug Market Size by Country (2020-2025)
9.4 Latin America Targeted Protein Degradation Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Protein Degradation Drug Market Size (2020-2031)
10.2 Middle East & Africa Targeted Protein Degradation Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Targeted Protein Degradation Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Targeted Protein Degradation Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arvinas
11.1.1 Arvinas Company Details
11.1.2 Arvinas Business Overview
11.1.3 Arvinas Targeted Protein Degradation Drug Introduction
11.1.4 Arvinas Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.1.5 Arvinas Recent Development
11.2 Kangpu Biopharmaceuticals
11.2.1 Kangpu Biopharmaceuticals Company Details
11.2.2 Kangpu Biopharmaceuticals Business Overview
11.2.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Introduction
11.2.4 Kangpu Biopharmaceuticals Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.2.5 Kangpu Biopharmaceuticals Recent Development
11.3 Ranok Therapeutics
11.3.1 Ranok Therapeutics Company Details
11.3.2 Ranok Therapeutics Business Overview
11.3.3 Ranok Therapeutics Targeted Protein Degradation Drug Introduction
11.3.4 Ranok Therapeutics Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.3.5 Ranok Therapeutics Recent Development
11.4 Accutar Biotechnology
11.4.1 Accutar Biotechnology Company Details
11.4.2 Accutar Biotechnology Business Overview
11.4.3 Accutar Biotechnology Targeted Protein Degradation Drug Introduction
11.4.4 Accutar Biotechnology Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.4.5 Accutar Biotechnology Recent Development
11.5 BeiGene Ltd.
11.5.1 BeiGene Ltd. Company Details
11.5.2 BeiGene Ltd. Business Overview
11.5.3 BeiGene Ltd. Targeted Protein Degradation Drug Introduction
11.5.4 BeiGene Ltd. Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.5.5 BeiGene Ltd. Recent Development
11.6 Hinova Pharmaceuticals
11.6.1 Hinova Pharmaceuticals Company Details
11.6.2 Hinova Pharmaceuticals Business Overview
11.6.3 Hinova Pharmaceuticals Targeted Protein Degradation Drug Introduction
11.6.4 Hinova Pharmaceuticals Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.6.5 Hinova Pharmaceuticals Recent Development
11.7 Haisco Pharmaceutical
11.7.1 Haisco Pharmaceutical Company Details
11.7.2 Haisco Pharmaceutical Business Overview
11.7.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Introduction
11.7.4 Haisco Pharmaceutical Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.7.5 Haisco Pharmaceutical Recent Development
11.8 Nurix
11.8.1 Nurix Company Details
11.8.2 Nurix Business Overview
11.8.3 Nurix Targeted Protein Degradation Drug Introduction
11.8.4 Nurix Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.8.5 Nurix Recent Development
11.9 Kymera Therapeutics
11.9.1 Kymera Therapeutics Company Details
11.9.2 Kymera Therapeutics Business Overview
11.9.3 Kymera Therapeutics Targeted Protein Degradation Drug Introduction
11.9.4 Kymera Therapeutics Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.9.5 Kymera Therapeutics Recent Development
11.10 C4 Therapeutics
11.10.1 C4 Therapeutics Company Details
11.10.2 C4 Therapeutics Business Overview
11.10.3 C4 Therapeutics Targeted Protein Degradation Drug Introduction
11.10.4 C4 Therapeutics Revenue in Targeted Protein Degradation Drug Business (2020-2025)
11.10.5 C4 Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Targeted Protein Degradation Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of PROTAC
 Table 3. Key Players of Molecular Glue
 Table 4. Global Targeted Protein Degradation Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Targeted Protein Degradation Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Targeted Protein Degradation Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Targeted Protein Degradation Drug Market Share by Region (2020-2025)
 Table 8. Global Targeted Protein Degradation Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Targeted Protein Degradation Drug Market Share by Region (2026-2031)
 Table 10. Targeted Protein Degradation Drug Market Trends
 Table 11. Targeted Protein Degradation Drug Market Drivers
 Table 12. Targeted Protein Degradation Drug Market Challenges
 Table 13. Targeted Protein Degradation Drug Market Restraints
 Table 14. Global Targeted Protein Degradation Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Targeted Protein Degradation Drug Market Share by Players (2020-2025)
 Table 16. Global Top Targeted Protein Degradation Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Protein Degradation Drug as of 2024)
 Table 17. Ranking of Global Top Targeted Protein Degradation Drug Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Targeted Protein Degradation Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Targeted Protein Degradation Drug, Headquarters and Area Served
 Table 20. Global Key Players of Targeted Protein Degradation Drug, Product and Application
 Table 21. Global Key Players of Targeted Protein Degradation Drug, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Targeted Protein Degradation Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Targeted Protein Degradation Drug Revenue Market Share by Type (2020-2025)
 Table 25. Global Targeted Protein Degradation Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Targeted Protein Degradation Drug Revenue Market Share by Type (2026-2031)
 Table 27. Global Targeted Protein Degradation Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Targeted Protein Degradation Drug Revenue Market Share by Application (2020-2025)
 Table 29. Global Targeted Protein Degradation Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Targeted Protein Degradation Drug Revenue Market Share by Application (2026-2031)
 Table 31. North America Targeted Protein Degradation Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Targeted Protein Degradation Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Targeted Protein Degradation Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Targeted Protein Degradation Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Targeted Protein Degradation Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Targeted Protein Degradation Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Targeted Protein Degradation Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Targeted Protein Degradation Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Targeted Protein Degradation Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Targeted Protein Degradation Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Targeted Protein Degradation Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Targeted Protein Degradation Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Targeted Protein Degradation Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Targeted Protein Degradation Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Targeted Protein Degradation Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Arvinas Company Details
 Table 47. Arvinas Business Overview
 Table 48. Arvinas Targeted Protein Degradation Drug Product
 Table 49. Arvinas Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
 Table 50. Arvinas Recent Development
 Table 51. Kangpu Biopharmaceuticals Company Details
 Table 52. Kangpu Biopharmaceuticals Business Overview
 Table 53. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product
 Table 54. Kangpu Biopharmaceuticals Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
 Table 55. Kangpu Biopharmaceuticals Recent Development
 Table 56. Ranok Therapeutics Company Details
 Table 57. Ranok Therapeutics Business Overview
 Table 58. Ranok Therapeutics Targeted Protein Degradation Drug Product
 Table 59. Ranok Therapeutics Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
 Table 60. Ranok Therapeutics Recent Development
 Table 61. Accutar Biotechnology Company Details
 Table 62. Accutar Biotechnology Business Overview
 Table 63. Accutar Biotechnology Targeted Protein Degradation Drug Product
 Table 64. Accutar Biotechnology Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
 Table 65. Accutar Biotechnology Recent Development
 Table 66. BeiGene Ltd. Company Details
 Table 67. BeiGene Ltd. Business Overview
 Table 68. BeiGene Ltd. Targeted Protein Degradation Drug Product
 Table 69. BeiGene Ltd. Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
 Table 70. BeiGene Ltd. Recent Development
 Table 71. Hinova Pharmaceuticals Company Details
 Table 72. Hinova Pharmaceuticals Business Overview
 Table 73. Hinova Pharmaceuticals Targeted Protein Degradation Drug Product
 Table 74. Hinova Pharmaceuticals Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
 Table 75. Hinova Pharmaceuticals Recent Development
 Table 76. Haisco Pharmaceutical Company Details
 Table 77. Haisco Pharmaceutical Business Overview
 Table 78. Haisco Pharmaceutical Targeted Protein Degradation Drug Product
 Table 79. Haisco Pharmaceutical Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
 Table 80. Haisco Pharmaceutical Recent Development
 Table 81. Nurix Company Details
 Table 82. Nurix Business Overview
 Table 83. Nurix Targeted Protein Degradation Drug Product
 Table 84. Nurix Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
 Table 85. Nurix Recent Development
 Table 86. Kymera Therapeutics Company Details
 Table 87. Kymera Therapeutics Business Overview
 Table 88. Kymera Therapeutics Targeted Protein Degradation Drug Product
 Table 89. Kymera Therapeutics Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
 Table 90. Kymera Therapeutics Recent Development
 Table 91. C4 Therapeutics Company Details
 Table 92. C4 Therapeutics Business Overview
 Table 93. C4 Therapeutics Targeted Protein Degradation Drug Product
 Table 94. C4 Therapeutics Revenue in Targeted Protein Degradation Drug Business (2020-2025) & (US$ Million)
 Table 95. C4 Therapeutics Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Targeted Protein Degradation Drug Picture
 Figure 2. Global Targeted Protein Degradation Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Targeted Protein Degradation Drug Market Share by Type: 2024 VS 2031
 Figure 4. PROTAC Features
 Figure 5. Molecular Glue Features
 Figure 6. Global Targeted Protein Degradation Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Targeted Protein Degradation Drug Market Share by Application: 2024 VS 2031
 Figure 8. Cancer Case Studies
 Figure 9. Autoimmune Diseases Case Studies
 Figure 10. Other Case Studies
 Figure 11. Targeted Protein Degradation Drug Report Years Considered
 Figure 12. Global Targeted Protein Degradation Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Targeted Protein Degradation Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Targeted Protein Degradation Drug Market Share by Region: 2024 VS 2031
 Figure 15. Global Targeted Protein Degradation Drug Market Share by Players in 2024
 Figure 16. Global Top Targeted Protein Degradation Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Protein Degradation Drug as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Targeted Protein Degradation Drug Revenue in 2024
 Figure 18. North America Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Targeted Protein Degradation Drug Market Share by Country (2020-2031)
 Figure 20. United States Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Targeted Protein Degradation Drug Market Share by Country (2020-2031)
 Figure 24. Germany Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Targeted Protein Degradation Drug Market Share by Region (2020-2031)
 Figure 32. China Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Targeted Protein Degradation Drug Market Share by Country (2020-2031)
 Figure 40. Mexico Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Targeted Protein Degradation Drug Market Share by Country (2020-2031)
 Figure 44. Turkey Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Targeted Protein Degradation Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Arvinas Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
 Figure 48. Kangpu Biopharmaceuticals Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
 Figure 49. Ranok Therapeutics Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
 Figure 50. Accutar Biotechnology Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
 Figure 51. BeiGene Ltd. Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
 Figure 52. Hinova Pharmaceuticals Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
 Figure 53. Haisco Pharmaceutical Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
 Figure 54. Nurix Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
 Figure 55. Kymera Therapeutics Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
 Figure 56. C4 Therapeutics Revenue Growth Rate in Targeted Protein Degradation Drug Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart